糖尿病ラットにおけるソマトスタチン誘導体 (SMS 201-995) の腎機能および尿蛋白排泄に及ぼす影響

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Unknown venue

• Publication date

  1990-07-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.11213/TONYOBYO1958.33.531
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Antidiuretic effect of Sandostatin (SMS 201-995) in healthy volunteers.

  1989cited by this paper
• The effects of SMS 201-995 (sandostatin) on metabolic profiles in insulin-dependent diabetes mellitus.

  1989cited by this paper
• Treatment of orthostatic hypotension with octreotide.

  1989cited by this paper
• Experimental Atherosclerosis-Like Lesions Induced by Hyperinsulinism in Wistar Rats

  1989cited by this paper
• Prevention of the Dawn phenomenon (early morning hyperglycemia) in insulin-dependent diabetes mellitus by bedtime intranasal administration of a long-acting somatostatin analog.

  1988cited by this paper
• Effect of SMS 201–995 in Rapidly Progressive Diabetic Retinopathy

  1988cited by this paper
• The effect of a somatostatin analogue (SMS 201-995, Sandostatin) on the concentration of phosphoribosyl pyrophosphate and the activity of the pentose phosphate pathway in the early renal hypertrophy of experimental diabetes in the rat.

  1988cited by this paper
• Postprandial Glycaemic Effects of a Long-Acting Somatostatin Analogue (Octreotide) in Non-Insulin Dependent Diabetes Mellitus

  1988cited by this paper
• Renal response to intravenous somatostatin in insulin-dependent diabetic patients and normal subjects.

  1987cited by this paper
• Suppression of growth hormone and somatomedin C by long-acting somatostatin analog SMS 201-995 in type I diabetes mellitus.

  1987cited by this paper
• Effect of a somatostatin analogue, SMS 201-995, on 133Xe clearance from colonic mucosa in unanesthetized man.

  1987cited by this paper
• Treatment of diabetic diarrhea and orthostatic hypotension with somatostatin analogue SMS 201-995.

  1987cited by this paper
• EFFECTS OF SOMATOSTATIN ANALOGUE SMS 201–995 IN NORMAL MAN

  1986cited by this paper
• Effects of SMS 201-995 on intermediary metabolism and endocrine status in normal and diabetic humans.

  1986cited by this paper
• Effects of somatostatin and SMS 201-995 on carbohydrate metabolism in normal man.

  1986cited by this paper
• Somatostatin analog SMS 201-995 and insulin needs in insulin-dependent diabetic patients studied by means of an artificial pancreas.

  1986cited by this paper
• Treatment of autonomic neuropathy with a somatostatin analogue SMS-201-995.

  1986cited by this paper
• Early glomerular hyperfiltration in insulin-dependent diabetics and late nephropathy.

  1986cited by this paper
• SOMATOSTATIN AND WATER EXCRETION IN MAN: AN INTRARENAL ACTION

  1985cited by this paper
• Reduced Postprandial Hyperglycemia After Subcutaneous Injection of a Somatostatin-Analogue (SMS 201-995) in Insulin-dependent Diabetes Mellitus

  1985cited by this paper
• Effects of a somatostatin analogue SMS 201‐995 on hepatic haemodynamics in the pig and on intravariceal pressure in man

  1985cited by this paper
• Effects of a long-acting somatostatin analogue on postprandial hyperglycemia in insulin-dependent diabetes mellitus.

  1983cited by this paper
• Focal glomerulosclerosis in patients with unilateral nephrectomy.

  1983cited by this paper
• Effect of intravenous somatostatin on hemodynamics, regional blood flow, gastrointestinal hormones, and renal function in the dog

  1983cited by this paper
• Somatostatin.

  1983cited by this paper
• SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action.

  1982cited by this paper
• Mesangial function and glomerular sclerosis in rats after unilateral nephrectomy.

  1982cited by this paper
• Kidney function and size in type 1 (insulin-dependent) diabetic patients before and during growth hormone administration for one week

  1982cited by this paper
• The role of glomerular hyperfiltration in the initiation and progression of diabetic nephropathy.

  1981cited by this paper
• Rapid changes in kidney function--factors influencing kidney function in diabetics and normal man.

  1981cited by this paper
• The effect of glucagon infusion on kidney function in short-term insulin-dependent juvenile diabetics

  1980cited by this paper
• Reduction in Portal Vein Blood Flow by Somatostatin

  1979cited by this paper
• Metabolic effects of somatostatin in maturity-onset diabetes.

  1977cited by this paper
• An intrarenal effect of somatostatin on water excretion.

  1977cited by this paper
• Direct inhibition of gastric acid and pepsin secretion by growth-hormone release-inhibiting hormone in cats.

  1975cited by this paper
• A new method for labelling protein hormones with radioiodine for use in the radioimmunoassay.

  1972cited by this paper
• Nonprecipitating insulin antibodies.

  1958cited by this paper

• No citing papers are available for this paper.